MEDIUM confidence: 100% data completeness, but the composite (50) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5.1B— | $5.5B+7.4% | $4.8B-13.0% | $4.2B-12.5% | $4.1B-2.2% |
| EPS (dil.) | $8.97— | $7.81-12.9% | $6.13-21.5% | $3.69-39.8% | $3.08-16.5% |
| Free Cash Flow | $1.1B— | $915M-18.3% | $1.6B+77.1% | $1.7B+2.9% | $1.1B-33.7% |
| Gross Margin | 49.2% | 47.5%-1.7pp | 44.2%-3.3pp | 41.2%-3.0pp | 41.2%-0.0pp |
| Operating Margin | 31.6% | 27.8%-3.7pp | 23.6%-4.3pp | 15.3%-8.3pp | 12.2%-3.0pp |
| Net Margin | 29.3% | 23.2%-6.1pp | 20.6%-2.7pp | 14.3%-6.3pp | 11.7%-2.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 3.0%/yr (revenue basis).
Base free cash flow $1.5B (avg FY2023–FY2025; latest year $1.1B) · equity value $13.2B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Avg target $88 (last qtr, 6 analysts) → $91 (last mo, 5) (+4.0%).
Buy-rated share 19% → 13% over ~3 months (-7pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.03 | $1.08 | +4.9% |
| May 2026 | $1.04 | $1.15 | +10.6% |
| Feb 2026 | $1.40 | $1.54 | +10.0% |
| Oct 2025 | $1.52 | $1.76 | +15.8% |
| Aug 2025 | $1.24 | $1.33 | +7.3% |
| May 2025 | $1.20 | $1.24 | +3.3% |
| Feb 2025 | $1.57 | $1.60 | +1.9% |
| Nov 2024 | $1.52 | $1.55 | +2.0% |
The QScore of 50 for SWKS indicates a neutral outlook, driven by a mix of factors. The stock scores high on momentum, with a 43% return over the past three months and a bullish moving average trend, but is held back by low growth scores due to negative revenue and earnings growth. SWKS trades at a premium, with a P/E of 45.2, but exhibits strong recent price action, with a 12-month return of 11.3% and an RSI of 88.8, while its long-term and short-term scores are relatively close, with the short-term score slightly higher at 52.